Skip to main content

Amitriptyline

ADVERTISEMENT
Identification
Molecular formula
C20H23N1O1
CAS number
50-48-6
IUPAC name
3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N-methyl-propan-1-amine
State
State

At room temperature, amitriptyline is in the form of a solid.

Melting point (Celsius)
196.00
Melting point (Kelvin)
469.15
Boiling point (Celsius)
302.00
Boiling point (Kelvin)
575.15
General information
Molecular weight
277.40g/mol
Molar mass
277.4030g/mol
Density
1.0050g/cm3
Appearence

Amitriptyline is typically encountered as a white to slightly yellow crystalline powder. It is often odorless and is hygroscopic.

Comment on solubility

Solubility of 3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N-methyl-propan-1-amine

When discussing the solubility of the compound 3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N-methyl-propan-1-amine (C20H23N1O1), there are several important factors to consider:

  • Solvent Polarity: The solubility is significantly influenced by the polarity of the solvent. As a general rule, "like dissolves like," meaning that nonpolar compounds typically dissolve well in nonpolar solvents, whereas polar compounds prefer polar solvents.
  • Functional Groups: The presence of functional groups, such as amines in this compound, can affect solubility, often increasing its solubility in water due to the potential for hydrogen bonding.
  • Molecular Structure: The complex structure featuring a benzo[c][1]benzoxepin system may hinder solubility due to steric factors and crystallinity, leading to reduced interactions with solvents.

In summary, the solubility of C20H23N1O1 can vary depending on the chosen solvent and conditions, emphasizing the need for detailed investigations. It is often recommended to conduct solubility tests under various conditions to ascertain precise solubility characteristics.

Ultimately, understanding solubility is critical in the fields of pharmaceuticals and materials science, as it directly impacts the efficacy and functionality of chemical compounds.

Interesting facts

3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N-methyl-propan-1-amine

This intriguing compound showcases a fascinating blend of structural elements that contribute to its unique properties and potential applications. As a member of the larger category of benzoxepins, it presents an interesting target for researchers exploring its multifaceted chemical behavior and biological activities.

Key Features:

  • Complex Structure: The presence of both the benzo[c][1]benzoxepin moiety and the propan-1-amine fragment illustrates a rich chemical architecture, leading to diverse reactivity and potential interaction profiles.
  • Biological Interest: Compounds related to this structure have garnered attention in pharmacology, with many exhibiting noteworthy effects, particularly in areas such as neurochemistry and behavioral science.
  • Synthetic Challenges: The synthesis of such complex structures often presents unique challenges, demanding innovative strategies and techniques in organic chemistry to achieve the desired compounds efficiently.
  • Pharmacophore Potential: Understanding the *pharmacophore* – the part of the molecule responsible for its biological activity – may yield insights that can lead to the development of new therapeutic agents.

As chemists and researchers delve into the properties and possibilities of 3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N-methyl-propan-1-amine, they not only unlock the secrets of its structure but also pave the way for exciting advancements in medicinal chemistry. The journey into the realm of such compounds can inspire future discoveries and innovations.

Synonyms
Desmethyldoxepin
DTXSID9075406
1-Propanamine, 3-dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-
1225-56-5
3-dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-1-propanamine
1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N-methyl-
Desmethyldoxepin (cis/trans)
SCHEMBL9178473
DTXCID9033765
HVKCEFHNSNZIHO-UHFFFAOYSA-N
(E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine ((E,Z)-Desmethyldoxepin)
NS00122094
Desmethyldoxepin (cis/trans) 1.0 mg/ml in Methanol
1-Propanamine, 3-dibenzb,eoxepin-11(6H)-ylidene-N-methyl-